Frontline hyper-CVAD plus ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Updated results of a phase II study.
暂无分享，去创建一个
M. Konopleva | Z. Estrov | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | C. Dinardo | S. O'brien | Deborah A. Thomas | N. Pemmaraju | N. Jain | N. Short | W. Wierda | K. Sasaki | M. Yilmaz | R. Garris | Vicky Jeanis | D. Thomas